Losartan Potassium Prescription Bottles (Sandoz) – Quality Issue (2019)
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Consumer Product Safety Commission (CPSC)
Product
Losartan Potassium and Ezetimibe prescription drug bottles
Lot Codes / Batch Numbers
Not specified in CPSC notice. Check official source for details.
Product Images
Source: U.S. Consumer Product Safety Commission
A manufacturer is recalling Losartan Potassium and Ezetimibe prescription drug bottles. The hazard is: The prescription drug packaging is not child resistant as required by the Poison Prevention Packagin. Based on CPSC recall notice.
Summary derived from CPSC notice
The following details were not provided by CPSC: UPC codes.
Reason for Recall
As stated by CPSC
This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. The recalled bottles have "Sandoz," the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. The recall includes the following: Recalled Prescription Drugs NDC Numbers Lot Numbers Expiration Date Ezetimibe 10mg Tablets 0781-5690-31 JE4491 Aug-2020 30 count bottle JE4492 Aug-2020 JE4493 Aug-2020 JE4495 Aug-2020 JG0308 Sep-2020 JG0310 Sep-2020 JG0311 Sep-2020 JG0312 Sep-2020 JG5061 Sep-2020 JG5063 Sep-2020 JK8921 Oct-2020 JK8922 Oct-2020 JK8923 Oct-2020 JK8924 Oct-2020 JL5535 Oct-2020 JM2253 Oct-2020 JM2254 Oct-2020 JM2255 Oct-2020 JM2257 Oct-2020 JM2258 Oct-2020 JM2259 Oct-2020 JM5986 Oct-2020 JM5987 Oct-2020 Ezetimibe 10mg Tablets 0781-5690-92 JE4481 Aug-2020 90 count bottle JG0249 Sep-2020 JK8989 Oct-2020 JN0764 Jan-2021 Losartan Potassium 50mg Tablets 0781-5701-31 HV9471 Feb-2020 30 count bottle
Reported concern (CPSC)
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
Recommended Action
Per CPSC guidance
Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
Verify this information on the official source
For complete details and official instructions, check the U.S. Consumer Product Safety Commission (CPSC) directly.
View official CPSC recall noticePage updated: Jan 9, 2026